Get started
Author

Marco Capezzone

Observed names: Capezzone M, M Capezzone, M. Capezzone
Observed institutions: University of Siena, University of Pisa, Boston University, University of California, Los Angeles, Ospedale Santa Maria alle Scotte, Ospedale Misericordia - Grosseto, Azienda Ospedaliera Universitaria Pisana
ORCID: 0000-0001-8624-5831
Observed ORCID: 0000-0001-8624-5831
OpenAlex ID: A5073272994
Disappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens
2003 · Luca Chiovato, Francesco Latrofa, et al. · Annals of Internal Medicine · 361
Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of Cytology
2010 · Silvia Cantara, Marco Capezzone, et al. · The Journal of Clinical Endocrinology & Metabolism · 315
Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment
2002 · F. Pacini, M. Capezzone, et al. · The Journal of Clinical Endocrinology & Metabolism · 296
PDF
Outcome of Differentiated Thyroid Cancer with Detectable Serum Tg and Negative Diagnostic 131I Whole Body Scan: Comparison of Patients Treated with High 131I Activities Versus Untreated Patients
2001 · F. Pacini, L. Agate, et al. · The Journal of Clinical Endocrinology & Metabolism · 263
Minimally invasive video-assisted thyroidectomy for papillary carcinoma: A prospective study of its completeness
2002 · Paolo Miccoli, Rossella Elisei, et al. · Surgery · 216
Prediction of Disease Status by Recombinant Human TSH-Stimulated Serum Tg in the Postsurgical Follow-Up of Differentiated Thyroid Carcinoma
2001 · Furio Pacini, Eleonora Molinaro, et al. · The Journal of Clinical Endocrinology & Metabolism · 183
Contralateral Papillary Thyroid Cancer is Frequent at Completion Thyroidectomy with No Difference in Low- and High-Risk Patients
2001 · F. Pacini, R. Elisei, et al. · Thyroid · 155
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity
2008 · M Capezzone, S Marchisotta, et al. · Endocrine Related Cancer · 152
PDF
Limited Value of Repeat Recombinant Human Thyrotropin (rhTSH)-Stimulated Thyroglobulin Testing in Differentiated Thyroid Carcinoma Patients with Previous Negative rhTSH-Stimulated Thyroglobulin and Undetectable Basal Serum Thyroglobulin Levels
2007 · M. G. Castagna, L. Brilli, et al. · The Journal of Clinical Endocrinology & Metabolism · 129
Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH
2001 · F Lippi, M Capezzone, et al. · European Journal of Endocrinology · 110
Clinical Features and Therapeutic Implication of Papillary Thyroid Microcarcinoma
2007 · Kalliopi Pazaitou-Panayiotou, Marco Capezzone, et al. · Thyroid · 103
Short Telomeres, Telomerase Reverse Transcriptase Gene Amplification, and Increased Telomerase Activity in the Blood of Familial Papillary Thyroid Cancer Patients
2008 · Marco Capezzone, Silvia Cantara, et al. · The Journal of Clinical Endocrinology & Metabolism · 88
Familial non-medullary thyroid cancer: a critical review
2020 · M. Capezzone, E. Robenshtok, et al. · Journal of Endocrinological Investigation · 75
PDF
Activation of Nicotinamide N-Methyltransferase Gene Promoter by Hepatocyte Nuclear Factor-1β in Human Papillary Thyroid Cancer Cells
2004 · Jimin Xu, Marco Capezzone, et al. · Molecular Endocrinology · 65
RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma
2001 · F Basolo, E Molinaro, et al. · European Journal of Endocrinology · 58
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer
2012 · Silvia Cantara, Milena Pisu, et al. · The Journal of Clinical Endocrinology & Metabolism · 41
Telomere Length in Neoplastic and Nonneoplastic Tissues of Patients with Familial and Sporadic Papillary Thyroid Cancer
2011 · Marco Capezzone, Silvia Cantara, et al. · The Journal of Clinical Endocrinology & Metabolism · 37
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens
2003 · L. Chiovato, F. Latrofa, et al. · L Endocrinologo · 33
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor
2018 · M. G. Castagna, R. Forleo, et al. · Journal of Endocrinological Investigation · 31
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer
2010 · Silvia Cantara, Serena Capuano, et al. · Thyroid Research · 24
PDF
Prospective Validation of ATA and ETA Sonographic Pattern Risk of Thyroid Nodules Selected for FNAC
2018 · Fabio Maino, Raffaella Forleo, et al. · The Journal of Clinical Endocrinology & Metabolism · 21
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres
2012 · Silvia Cantara, Serena Capuano, et al. · Thyroid · 20
Should familial disease be considered as a negative prognostic factor in micropapillary thyroid carcinoma?
2019 · M. Capezzone, C. Secchi, et al. · Journal of Endocrinological Investigation · 19
Telomeres and Thyroid Cancer
2009 · Marco Capezzone, Stefania Marchisotta, et al. · Current Genomics · 19
PDF
Silent thyroiditis following vaccination against COVID-19: report of two cases
2022 · M. Capezzone, M. Tosti-Balducci, et al. · Journal of Endocrinological Investigation · 17
PDF
Works count: 59
Citation count: 3,013
H-index: 21
I10-index: 33
Year
Topic
Type